Effects of micrometer compound rhizoma coptidis on nuclear factor-κB and inflammatory factors in rabbit fed with high lipid diet

Zhongguo Zhongyao Zazhi

Volumn 32, Issue 12, 2007, Pages 1207-1210

  Wang, Bin ^a   Guan, Si ming ^a   Li, Xi dong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

C Reactive protein; Interleukin 1; Micrometer; Nuclear factor B; Rhizoma coptidis; Tumor necrosis factor

Indexed keywords

AUTACOID; C REACTIVE PROTEIN; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MESSENGER RNA; MICROSPHERE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; ATHEROGENIC DIET; BLOOD; CHEMISTRY; COPTIS; DRUG COMBINATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; ISOLATION AND PURIFICATION; MALE; MEDICINAL PLANT; METABOLISM; PARTICLE SIZE; POWDER; RABBIT; RANDOMIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORACIC AORTA;

ANIMALS; AORTA, THORACIC; C-REACTIVE PROTEIN; COPTIS; DIET, ATHEROGENIC; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION MEDIATORS; INTERLEUKIN-1; MALE; MICROSPHERES; NF-KAPPA B; PARTICLE SIZE; PLANTS, MEDICINAL; POWDERS; RABBITS; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547633658     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Monaco C, Paleolog E. Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis [J]. Cardiovasc Res, 2004,61(4):671.
2. Brand K, Page S, Rogler G, et al. Activated transcription factor nuclearfactor-kappa B is present in the atherosclerotic lesion[J]. J Clin Invest, 1996,97(7):1715.
3. Hajra L, Evans A I, Chen M, et al. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation [J]. Proc Natl Acad Sci USA, 2000,97(16):9052.
4. Dignam J D, Lebovitz R M, Roeder R G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei[J]. Nucleic Acids Res, 1983,11(5):1475.
5. Cercek B, Yamashita M, Dimayuga P, et al. Nuclear factor-κB activity and arterial response to ballon injury[J]. Atherosclerosis, 1997,131(1):59.
6. Libby P, Ridker P M, Maseri A. Inflammation and atherosclerosis[J]. Circulation, 2002,105(9):1135.
7. Collins T, Cybulsky M I. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis [J]. J Clin Invest, 2001,107(3):255.
8. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa] B activity[J]. Annu Rev Immunol, 2000,18(4):621.
9. Verma S, Yeh E T H. C-reactive proteinand atherosclerosis-beyond a biomarker: an actural partaker of lesion formation [J]. Am J Physiol Regul Integr Como Physiol, 2003,285(5):R1253.
10. Vitale C, Cerquetani E, Wayhgarten M, et al. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy[J]. Ital Heart J, 2003,4(9):627.
11. Willerson J T. Systemic and local inflammation and atherosclerosis[J]. Circulation, 2002,44(3):469.
12. Nam K W, Kim J, Hong J J, et al. Inhibition of cytokine-induced IkappaB kinase activation as a mechanism contributing to the anti-atherogenic activity of tilianin in hyperlipidemic mice [J]. Atherosclerosis, 2005,180(1):27.